STOCK TITAN

[144] Dynatrace, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144
Rhea-AI Filing Summary

Dynatrace, Inc. (DT) filed a Form 144 indicating a proposed sale of 1,013 shares of common stock through Morgan Stanley Smith Barney LLC on the NYSE with an approximate sale date of 09/05/2025. The filing reports an aggregate market value of $50,417.01 and shows 301,506,242 shares outstanding, implying the sale is a very small fraction of the company's share count. The shares were acquired as restricted stock from the issuer on 09/04/2025 and payment is recorded as made on 09/04/2025. The filer reports no other securities sold in the past three months and includes the standard attestation that no undisclosed material adverse information is known.

Dynatrace, Inc. (DT) ha presentato un modulo Form 144 relativo alla proposta di vendita di 1.013 azioni ordinarie tramite Morgan Stanley Smith Barney LLC sul NYSE, con data di vendita prevista approssimativa 09/05/2025. La segnalazione indica un valore di mercato complessivo di circa $50.417,01 e riporta 301.506.242 azioni in circolazione, suggerendo che la vendita rappresenta una frazione molto piccola del capitale sociale. Le azioni sono state acquisite come restricted stock dall'emittente il 09/04/2025 e il pagamento risulta effettuato in pari data 09/04/2025. Il dichiarante non riporta altre vendite di titoli negli ultimi tre mesi e include l'attestazione standard di assenza di informazioni materiali sfavorevoli non divulgate.

Dynatrace, Inc. (DT) presentó un Formulario 144 indicando la propuesta de venta de 1.013 acciones ordinarias a través de Morgan Stanley Smith Barney LLC en la NYSE, con fecha de venta aproximada 09/05/2025. El informe señala un valor de mercado agregado de $50,417.01 y muestra 301,506,242 acciones en circulación, lo que implica que la operación constituye una fracción muy pequeña del total de acciones de la compañía. Las acciones fueron adquiridas como restricted stock del emisor el 09/04/2025 y el pago figura realizado el 09/04/2025. El declarante no reporta otras ventas de valores en los últimos tres meses e incluye la certificación estándar de que no conoce información material adversa no divulgada.

Dynatrace, Inc. (DT)는 Morgan Stanley Smith Barney LLC를 통해 NYSE에서 보통주 1,013주 매각을 제안하는 Form 144를 제출했으며, 예정 매각일은 대략 2025-09-05로 기재되어 있습니다. 신고서에는 총 시가가 약 $50,417.01로 기재되어 있고, 유통 주식 수는 301,506,242주로 보고되어 이번 매각이 회사 전체 주식 수에 비해 매우 작은 비중임을 시사합니다. 해당 주식은 restricted stock으로 발행사로부터 2025-09-04에 취득되었으며, 대금도 2025-09-04에 지급된 것으로 기록되어 있습니다. 신고인은 최근 3개월 이내에 다른 증권을 매도한 사실이 없음을 보고했으며, 공개되지 않은 중대한 불리한 정보가 없다는 표준 서약을 포함하고 있습니다.

Dynatrace, Inc. (DT) a déposé un formulaire 144 indiquant une vente proposée de 1 013 actions ordinaires via Morgan Stanley Smith Barney LLC sur le NYSE, avec une date de vente approximative au 05/09/2025. Le dépôt fait état d'une valeur de marché globale d'environ 50 417,01 $ et signale 301 506 242 actions en circulation, ce qui implique que la vente représente une fraction très faible du capital social de la société. Les actions ont été acquises en tant que restricted stock auprès de l'émetteur le 04/09/2025 et le paiement est enregistré comme effectué le 04/09/2025. Le déclarant ne signale aucune autre vente de titres au cours des trois derniers mois et inclut l'attestation standard selon laquelle il n'a pas connaissance d'informations défavorables importantes non divulguées.

Dynatrace, Inc. (DT) reichte ein Formular 144 ein, das einen geplanten Verkauf von 1.013 Stammaktien über Morgan Stanley Smith Barney LLC an der NYSE mit einem ungefähren Verkaufsdatum 05.09.2025 angibt. Die Meldung nennt einen aggregierten Marktwert von $50.417,01 und weist 301.506.242 ausstehende Aktien aus, was darauf hindeutet, dass der Verkauf einen sehr kleinen Anteil am Aktienbestand des Unternehmens darstellt. Die Aktien wurden als restricted stock vom Emittenten am 04.09.2025 erworben und die Zahlung ist am 04.09.2025 erfolgt. Der Melder gibt an, in den letzten drei Monaten keine weiteren Wertpapiere verkauft zu haben, und fügt die übliche Bestätigung hinzu, dass keine nicht offengelegten wesentlichen nachteiligen Informationen bekannt sind.

Positive
  • None.
Negative
  • None.

Insights

TL;DR Routine small insider sale of recently issued restricted shares; immaterial to company valuation.

This Form 144 documents a proposed sale of 1,013 restricted shares acquired from the issuer one day prior, with an aggregate value of $50,417.01 against 301,506,242 outstanding shares. The timing—acquisition on 09/04/2025 and proposed sale on 09/05/2025—suggests disposition of newly vested or otherwise transferable restricted stock, likely following an internal vesting or settlement event. From an investor perspective, the size of the sale is negligible relative to total shares outstanding and is consistent with routine insider liquidity rather than signaling material corporate developments.

TL;DR Disclosure appears to meet Rule 144 notice requirements; no material governance concerns evident.

The filing identifies the broker and provides acquisition details showing the securities were received from the issuer as restricted stock and paid for on 09/04/2025. The filer attests to lacking undisclosed material adverse information and reports no other sales in the prior three months. There are no indications of expedited or atypical insider selling patterns in this notice. Documentation appears routine and compliant with Rule 144 notice provisions based on the provided fields.

Dynatrace, Inc. (DT) ha presentato un modulo Form 144 relativo alla proposta di vendita di 1.013 azioni ordinarie tramite Morgan Stanley Smith Barney LLC sul NYSE, con data di vendita prevista approssimativa 09/05/2025. La segnalazione indica un valore di mercato complessivo di circa $50.417,01 e riporta 301.506.242 azioni in circolazione, suggerendo che la vendita rappresenta una frazione molto piccola del capitale sociale. Le azioni sono state acquisite come restricted stock dall'emittente il 09/04/2025 e il pagamento risulta effettuato in pari data 09/04/2025. Il dichiarante non riporta altre vendite di titoli negli ultimi tre mesi e include l'attestazione standard di assenza di informazioni materiali sfavorevoli non divulgate.

Dynatrace, Inc. (DT) presentó un Formulario 144 indicando la propuesta de venta de 1.013 acciones ordinarias a través de Morgan Stanley Smith Barney LLC en la NYSE, con fecha de venta aproximada 09/05/2025. El informe señala un valor de mercado agregado de $50,417.01 y muestra 301,506,242 acciones en circulación, lo que implica que la operación constituye una fracción muy pequeña del total de acciones de la compañía. Las acciones fueron adquiridas como restricted stock del emisor el 09/04/2025 y el pago figura realizado el 09/04/2025. El declarante no reporta otras ventas de valores en los últimos tres meses e incluye la certificación estándar de que no conoce información material adversa no divulgada.

Dynatrace, Inc. (DT)는 Morgan Stanley Smith Barney LLC를 통해 NYSE에서 보통주 1,013주 매각을 제안하는 Form 144를 제출했으며, 예정 매각일은 대략 2025-09-05로 기재되어 있습니다. 신고서에는 총 시가가 약 $50,417.01로 기재되어 있고, 유통 주식 수는 301,506,242주로 보고되어 이번 매각이 회사 전체 주식 수에 비해 매우 작은 비중임을 시사합니다. 해당 주식은 restricted stock으로 발행사로부터 2025-09-04에 취득되었으며, 대금도 2025-09-04에 지급된 것으로 기록되어 있습니다. 신고인은 최근 3개월 이내에 다른 증권을 매도한 사실이 없음을 보고했으며, 공개되지 않은 중대한 불리한 정보가 없다는 표준 서약을 포함하고 있습니다.

Dynatrace, Inc. (DT) a déposé un formulaire 144 indiquant une vente proposée de 1 013 actions ordinaires via Morgan Stanley Smith Barney LLC sur le NYSE, avec une date de vente approximative au 05/09/2025. Le dépôt fait état d'une valeur de marché globale d'environ 50 417,01 $ et signale 301 506 242 actions en circulation, ce qui implique que la vente représente une fraction très faible du capital social de la société. Les actions ont été acquises en tant que restricted stock auprès de l'émetteur le 04/09/2025 et le paiement est enregistré comme effectué le 04/09/2025. Le déclarant ne signale aucune autre vente de titres au cours des trois derniers mois et inclut l'attestation standard selon laquelle il n'a pas connaissance d'informations défavorables importantes non divulguées.

Dynatrace, Inc. (DT) reichte ein Formular 144 ein, das einen geplanten Verkauf von 1.013 Stammaktien über Morgan Stanley Smith Barney LLC an der NYSE mit einem ungefähren Verkaufsdatum 05.09.2025 angibt. Die Meldung nennt einen aggregierten Marktwert von $50.417,01 und weist 301.506.242 ausstehende Aktien aus, was darauf hindeutet, dass der Verkauf einen sehr kleinen Anteil am Aktienbestand des Unternehmens darstellt. Die Aktien wurden als restricted stock vom Emittenten am 04.09.2025 erworben und die Zahlung ist am 04.09.2025 erfolgt. Der Melder gibt an, in den letzten drei Monaten keine weiteren Wertpapiere verkauft zu haben, und fügt die übliche Bestätigung hinzu, dass keine nicht offengelegten wesentlichen nachteiligen Informationen bekannt sind.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What did Dynatrace (DT) disclose in this Form 144?

The Form 144 reports a proposed sale of 1,013 common shares with an aggregate market value of $50,417.01 through Morgan Stanley Smith Barney LLC on the NYSE with an approximate sale date of 09/05/2025.

When were the shares acquired and what was the nature of acquisition?

The shares were acquired on 09/04/2025 as restricted stock from the issuer, with payment recorded on 09/04/2025.

How large is the proposed sale relative to Dynatrace's outstanding shares?

The filing lists 301,506,242 shares outstanding; the proposed sale of 1,013 shares represents an immaterial fraction of total shares outstanding.

Does the filer report other sales by the same person in the past three months?

No. The filing states "Nothing to Report" for securities sold during the past three months by the person for whose account the securities are to be sold.

Which broker is handling the proposed sale?

The broker named in the filing is Morgan Stanley Smith Barney LLC, Executive Financial Services, 1 New York Plaza, 8th Floor, New York, NY 10004.
Dynatrace Inc

NYSE:DT

DT Rankings

DT Latest News

DT Latest SEC Filings

DT Stock Data

15.01B
298.83M
0.49%
101.51%
2.35%
Software - Application
Services-prepackaged Software
Link
United States
BOSTON